A randomized placebo-controlled phase II/III with celecoxib in patients with locally advanced or metastatic non-small cell lung cancer.

Trial Profile

A randomized placebo-controlled phase II/III with celecoxib in patients with locally advanced or metastatic non-small cell lung cancer.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 01 Jan 2010

At a glance

  • Drugs Celecoxib (Primary) ; Carboplatin; Docetaxel
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Acronyms NVALT4
  • Most Recent Events

    • 04 Aug 2009 Results have been represented at the 13th World Conference on Lung Cancer.
    • 29 May 2009 Results presented at ASCO 2009.
    • 02 May 2009 Status changed from not stated to completed as reported by Netherlands Trial Register record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top